Pigment Cell & Melanoma Research

Cover image for Vol. 26 Issue 4

July 2013

Volume 26, Issue 4

Pages 433–601, E1–E14

  1. Editorial

    1. Top of page
    2. Editorial
    3. News and Views
    4. Perspectives
    5. Review
    6. Original Articles
    7. Short Communications
    8. Resource
    9. Corrigendum
    10. Meeting Reports
    1. The immune system in pigment cell biology: villain or hero? (page 433)

      Robert Kelsh, Heinz Arnheiter and Marcus Bosenberg

      Version of Record online: 26 JUN 2013 | DOI: 10.1111/pcmr.12128

  2. News and Views

    1. Top of page
    2. Editorial
    3. News and Views
    4. Perspectives
    5. Review
    6. Original Articles
    7. Short Communications
    8. Resource
    9. Corrigendum
    10. Meeting Reports
    1. Crossing the junction in the gap of melanoma brain metastasis (pages 435–437)

      Takafumi Kamiya, Aaron K. Mobley and Menashe Bar-Eli

      Version of Record online: 4 APR 2013 | DOI: 10.1111/pcmr.12095

      • image
  3. Perspectives

    1. Top of page
    2. Editorial
    3. News and Views
    4. Perspectives
    5. Review
    6. Original Articles
    7. Short Communications
    8. Resource
    9. Corrigendum
    10. Meeting Reports
  4. Review

    1. Top of page
    2. Editorial
    3. News and Views
    4. Perspectives
    5. Review
    6. Original Articles
    7. Short Communications
    8. Resource
    9. Corrigendum
    10. Meeting Reports
    1. You have free access to this content
      Targeting melanoma by small molecules: challenges ahead (pages 464–469)

      Rizwan Haq and David E. Fisher

      Version of Record online: 28 MAY 2013 | DOI: 10.1111/pcmr.12109

  5. Original Articles

    1. Top of page
    2. Editorial
    3. News and Views
    4. Perspectives
    5. Review
    6. Original Articles
    7. Short Communications
    8. Resource
    9. Corrigendum
    10. Meeting Reports
    1. The PKD domain distinguishes the trafficking and amyloidogenic properties of the pigment cell protein PMEL and its homologue GPNMB (pages 470–486)

      Alexander C. Theos, Brenda Watt, Dawn C. Harper, Karolina J. Janczura, Sarah C. Theos, Kathryn E. Herman and Michael S. Marks

      Version of Record online: 2 APR 2013 | DOI: 10.1111/pcmr.12084

      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image
    2. You have full text access to this OnlineOpen article
    3. Effects of BRAF inhibitors on human melanoma tissue before treatment, early during treatment, and on progression (pages 499–508)

      Georgina V. Long, James S. Wilmott, Lauren E. Haydu, Varsha Tembe, Raghwa Sharma, Helen Rizos, John F. Thompson, Julie Howle, Richard A. Scolyer and Richard F. Kefford

      Version of Record online: 3 MAY 2013 | DOI: 10.1111/pcmr.12098

      • image
      • image
      • image
      • image
    4. Secondary c-Kit mutations confer acquired resistance to RTK inhibitors in c-Kit mutant melanoma cells (pages 518–526)

      Jason R. Todd, Therese M. Becker, Richard F. Kefford and Helen Rizos

      Version of Record online: 13 MAY 2013 | DOI: 10.1111/pcmr.12107

      • image
      • image
      • image
      • image
      • image
    5. MERTK controls melanoma cell migration and survival and differentially regulates cell behavior relative to AXL (pages 527–541)

      Kathryn A. Tworkoski, James T. Platt, Antonella Bacchiocchi, Marcus Bosenberg, Titus J. Boggon and David F. Stern

      Version of Record online: 21 MAY 2013 | DOI: 10.1111/pcmr.12110

      • image
      • image
      • image
      • image
      • image
      • image
      • image
    6. Genome-wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanoma (pages 542–554)

      Linda Gao, Marjon A. Smit, Joost J. van den Oord, Jelle J. Goeman, Els M. E. Verdegaal, Sjoerd H. van der Burg, Marguerite Stas, Samuel Beck, Nelleke A. Gruis, Cornelis P. Tensen, Rein Willemze, Daniel S. Peeper and Remco van Doorn

      Version of Record online: 17 APR 2013 | DOI: 10.1111/pcmr.12096

      • image
      • image
      • image
      • image
    7. E-cadherin determines Caveolin-1 tumor suppression or metastasis enhancing function in melanoma cells (pages 555–570)

      Lorena Lobos-González, Lorena Aguilar, Jorge Diaz, Natalia Diaz, Hery Urra, Vicente A. Torres, Veronica Silva, Christopher Fitzpatrick, Alvaro Lladser, Keith S. Hoek, Lisette Leyton and Andrew F. G. Quest

      Version of Record online: 11 APR 2013 | DOI: 10.1111/pcmr.12085

      • image
      • image
      • image
      • image
      • image
      • image
      • image
    8. Differential expression and tumor necrosis factor-mediated regulation of TNFRSF11b/osteoprotegerin production by human melanomas (pages 571–579)

      Janine L. Oliver, Matthew P. Alexander, Allison G. Norrod, Irene M. Mullins and David W. Mullins

      Version of Record online: 11 APR 2013 | DOI: 10.1111/pcmr.12091

      • image
      • image
      • image
      • image
      • image
      • image
  6. Short Communications

    1. Top of page
    2. Editorial
    3. News and Views
    4. Perspectives
    5. Review
    6. Original Articles
    7. Short Communications
    8. Resource
    9. Corrigendum
    10. Meeting Reports
    1. Chk1 is essential for the development of murine epidermal melanocytes (pages 580–585)

      Joanne Smith, Lionel Larue and David A. Gillespie

      Version of Record online: 17 APR 2013 | DOI: 10.1111/pcmr.12100

      • image
      • image
      • image
    2. Decreased regulatory T-cells and CD4+/CD8+ ratio correlate with disease onset and progression in patients with generalized vitiligo (pages 586–591)

      Mitesh Dwivedi, Naresh C. Laddha, Prateek Arora, Yogesh S. Marfatia and Rasheedunnisa Begum

      Version of Record online: 13 MAY 2013 | DOI: 10.1111/pcmr.12105

      • image
      • image
    3. Resistance to cisplatin-induced cell death conferred by the activity of organic anion transporting polypeptides (OATP) in human melanoma cells (pages 592–596)

      Françoise Silvy, Jean-Claude Lissitzky, Nadine Bruneau, Nathalie Zucchini, Jean-François Landrier, Dominique Lombardo and Patrick Verrando

      Version of Record online: 3 MAY 2013 | DOI: 10.1111/pcmr.12108

      • image
      • image
  7. Resource

    1. Top of page
    2. Editorial
    3. News and Views
    4. Perspectives
    5. Review
    6. Original Articles
    7. Short Communications
    8. Resource
    9. Corrigendum
    10. Meeting Reports
    1. You have free access to this content
      The Ludwig Institute for Cancer Research Melbourne Melanoma Cell Line Panel (pages 597–600)

      Andreas Behren, Matthew Anaka, Pu-Han Lo, Laura J. Vella, Ian D. Davis, Jenny Catimel, Tracy Cardwell, Craig Gedye, Christopher Hudson, Rodica Stan and Jonathan Cebon

      Version of Record online: 11 APR 2013 | DOI: 10.1111/pcmr.12097

      • image
  8. Corrigendum

    1. Top of page
    2. Editorial
    3. News and Views
    4. Perspectives
    5. Review
    6. Original Articles
    7. Short Communications
    8. Resource
    9. Corrigendum
    10. Meeting Reports
    1. You have free access to this content
      Corrigendum (page 601)

      Version of Record online: 23 MAY 2013 | DOI: 10.1111/pcmr.12112

      This article corrects:
  9. Meeting Reports

    1. Top of page
    2. Editorial
    3. News and Views
    4. Perspectives
    5. Review
    6. Original Articles
    7. Short Communications
    8. Resource
    9. Corrigendum
    10. Meeting Reports
    1. Meeting report from the Society for Melanoma Research 2012 Congress, Hollywood, California (pages E1–E7)

      R. S. Lo, A. Ribas, G. V. Long, R. Ballotti, M. Berger, H. Willy, G. T. Gibney, M. Bosenberg, E. Bernstein, J. Villanueva and K. S. M. Smalley

      Version of Record online: 13 MAY 2013 | DOI: 10.1111/pcmr.12103

    2. Meeting report: The future of preclinical mouse models in melanoma treatment is now (pages E8–E14)

      Glenn Merlino, Keith Flaherty, Nicolas Acquavella, Chi-Ping Day, Andrew Aplin, Sheri Holmen, Suzanne Topalian, Terry Van Dyke and Meenhard Herlyn

      Version of Record online: 8 APR 2013 | DOI: 10.1111/pcmr.12099

SEARCH

SEARCH BY CITATION